Clinical Trial Update: Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 trial investigating albumin infusion effects on mortality in patients with cirrhosis and hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Drugs mentioned

• Albumin infusion (Human serum albumin)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Hepatic Encephalopathy, Cirrhosis | Phase 4 | Status: UNKNOWN